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ABSTRACT The role of structural signals in intercompartmental transport has been addressed 
by the isolation of yeast invertase (SUC2) mutations that cause intracellular accumulation of 
active enzyme. Two mutations that delay transport of core-glycosylated invertase, but not 
acid phosphatase, have been mapped in the 5' coding region of SUC2. Both mutations reduce 
specifically the transport of invertase to a compartment, presumably in the Golgi body, where 
outer chain carbohydrate is added. Subsequent transport to the cell surface is not similarly 
delayed. One mutation (SUC2-sl) converts an ala codon to val at position -1 in the signal 
peptide; the other (SUC2-s2) changes a thr to an lie at position +64 in the mature protein. 
Mutation sl results in about a 50-fold reduced rate of invertase transport to the Golgi body 
which is attributable to defective signal peptide cleavage. While peptide cleavage normally 
occurs at an ala-ser bond, the sl mutant form is processed slowly at the adjacent ser-met 
position giving rise to mature invertase with an N-terminal met residue, s2 mutant invertase is 
transported about sevenfold more slowly than normal, with no delay in signal peptide cleavage, 
and no detectable abnormal physical property of the enzyme. This substitution may interfere 
with the interaction of invertase and a receptor that facilitates transport to the Golgi body. 
The compartmentation of eucaryotic cells implies both spe- 
cific mechanisms for protein localization and identifying sig- 
nals that are recognized by the localization apparatus. Protein 
transport must betargeted not only to distinct organelles but 
to specific subdivisions within such organelles as the mito- 
chondrion, chloroplast, endoplasmic reticulum (ER), ~ Golgi 
body, and plasma membrane. This process probably involves 
a number of unique identifying signals of which only a few 
have been deciphered. Clearly distinct N-terminal signal pep- 
tides direct secretory, mitochondrial, and chloroplast precur- 
sors to their respective organelles (1-3); hydrophobic mem- 
brane anchoring sequences have been recognized in viral 
glycoproteins (4, 5) and surface-bound immunoglobulin (6); 
a cytoplasmic, C-terminal peptide has been implicated in 
rapid transport of vesicular stomatitis virus G protein from 
the ER (7); and oligosaccharide phosphorylation triggers the 
t Abbreviations used in this paper." E and I fractions, external and 
intraceilular fractions; endo H, endoglycosidase H; ER, endoplasmic 
reticulum; YPD medium, 1% Bacto-Yeast extract, 2% Bacto-pep- 
tone, and 2% glucose (YP medium, same but without glucose). 
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sorting of lysosomal enzymes in mammalian fibroblasts (8- 
10). 
A major question in the mechanism of secretion concerns 
the role of receptors in mediation of intracellular t ansport. 
The evidence for such receptors i  entirely circumstantial. 
Two examples that are consistent with a receptor are that the 
rate of transport from the ER to the Golgi body varies for 
different proteins in the same cell ( 11-13), and that movement 
of retinol-binding protein from the ER requires retinol, pre- 
sumably to alter the conformation ofthe binding protein (14). 
These cases could equally well be explained by selective 
negative influences on transport of slowly moving proteins. 
The challenge in this area is to develop evidence of a more 
positive nature, such as the identification of a signal or struc- 
ture required for transport. 
One method of defining localization signals in organellar 
proteins is the isolation of mutations in which these signals 
are defective so that the altered protein accumulates atsome 
point along the normal transport pathway or is misdirected 
to some other cellular organelle. The most revealing applica- 
tion of this approach as been in the definition of important 
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aspects of the signal peptide in secretion of bacterial proteins 
( 15-17). In eucaryotic ells, numerous examples of transport- 
deficient mutant forms of membrane and secretory proteins 
have been presented: IgA k light chain (18), low-density 
lipoprotein receptor (19), Vaccinia Virus hemagglutinin (20), 
arantitrypsin (2 l), vesicular stomatitis virus G protein (22- 
23, for review see reference 24). Defective proteins most often 
accumulate in the ER. Although some of these mutations 
may specifically affect a transport signal, it has been difficult 
to exclude the more trivial possibility that defective proteins 
are denatured or aggregated. 
Retention of full enzyme activity in a secretion-defective 
mutant protein is a criterion that may be used to distinguish 
a transport lesion from more general perturbations of protein 
structure. With this in mind, we have examined invertase, an 
enzyme that follows the normal secretory pathway in yeast 
(25). The invertase gene (SUC2) has been cloned and se- 
quenced (26, 27). Transformation of yeast cells with heavily 
mutagenized plasmid DNA has allowed a large number of 
SUC2 mutants to be screened for accumulation of active 
invertase. In this report we describe the isolation, characteri- 
zation, and precise mapping of two transport-specific muta- 
tions. 
MATERIALS AND METHODS 
Strains, Growth Conditions, and Materials: Saccharomyces 
cerevisiae strains SEY2101, SEY2102, and SEYS188 (all SUc2-A9), and 
SEY5186 (SUC2, secl8), were described previously (28, 29). ISYl-22A (urn3- 
52, leu2-3, leu2-112, his4-519, SUC2-A9, pho80-2) was constructed by standard 
genetic techniques. 
pRB58, a YEp24-derived 2 u plasmid (30) containing the SUC2 gene, was 
obtained from M. Carlson (Columbia University) and has been described 
elsewhere (26). Plasmids pSEY125, pSEY124, and pSEY122, which carry 
SUC2-1acZ fusions, have also been described elsewhere (29). pSEY8 was derived 
from pUC8 (31) and also contains 2 u DNA and the URA3 gene (30). 
YPD medium contained 1% Baeto-Yeast extract (Difco Laboratories Inc., 
Detroit, MI), 2% Bacto-peptone (Difco Laboratories Inc.), and 2% glucose. 
Wickerham's minimal medium (32) was used with various amounts of glucose 
or raffinose as a carbon source. For low sulfate medium, chloride salts replaced 
sulfate salts, and ammonium sulfate was added to the desired concentration. 
The absorbance of dilute cell suspensions was measured in a l-cm cuvette at 
600 nm in a Zeiss PMQII spectrophotometer, 10Dt,00 unit of cells corresponds 
to 0.15 mg dry wt. Liquid cultures were grown in flasks or tubes with agitation, 
and experiments were initiated with exponentially growing cells at an OD~o of 
0.5-4. 
Other reagents were obtained as indicated: glucose oxidase, peroxidase, o-
dianisidine, cycloheximide, cytochrome c, NADPH, ravin mononucleotide, 
triphenyltetrazolium chloride, tunicamycin, ATP, saponin, hydroxylamine, 
ergosterol, and tergitol Nonidet P-40 were from Sigma Chemical Co. (St. Louis, 
MO); H235SO4 and [3H]leucine were from Amersham Corp. (Arlington Heights, 
IL); ENHANCE was from New England Nuclear (Boston, MA); Beta Max was 
from West Chem (San Diego, CA); IgG Sorb was from The Enzyme Center 
Inc. (Boston, MA); restriction enzymes and T4 DNA ligase were from Bethesda 
Research Laboratories (Gaithersburg, MD); oleate was from Merck and Co. 
(Rahway, N J); BBL-Gas Pak anaerobic system catalyst and CO2 + H2 generator 
packs were from Fisher Scientific Co. (Pittsburgh, PA). Lyticase (fraction II) 
was used for production of spheroplasts. Endoglycosidase H (endo H) was 
obtained from P. Robbins (Massachusetts In titute of Technology). Acid phos- 
phatase antibody was obtained from Simone Straumann-B6hni and Gottfried 
Schatz (Biozentrum, University of Basel). 
Cytoplasmic nvertase was purified by the method of Goldstein and Lampen 
(33) and used to raise antibody by the multiple intradermal injection method 
(34). Immune serum, which had a titer of about l:l 6 to 1:32 against cytoplasmic 
invertase, was stored at -20"C (in l0 mM NAN3) and used without further 
purification. Immune precipitation samples were mixed with aliquots of an 
extract prepared from strain SEY2102. This strain, which had no invertase 
cross-reacting material, was grown to late logarithmic phase in YPD medium; 
cells were centrifuged and resuspended in PBS (12.5 mM sodium phosphate, 
pH 7.0, 200 mM sodium chloride) at ~800 ODr0o units of cells/ml and lysed 
by agitation for 5 min with glass beads (0.3-0.5 mm) in a Bead-Beater (Biospec 
Products, Bartlesville, OK). The extract was then adjusted to 1% SDS and 
heated in a boiling water bath for 6 min. A soluble fraction (30-40 mg protein/ 
ml) was obtained by centrifugtion for 20 min at 12,000 g. 
Mutagenesis and Mutant Screening: pRB58 plasmid DNA, 
purified by CsC1 density sedimentation, was diluted into a solution of 0.4 M 
hydroxylamine, 0.05 M potassium phosphate, pH 6.0, at a DNA concentration 
of 125 #g/ml. After 60 rain at 75"C, samples were chilled, and the DNA was 
precipitated with ethanol, resuspended in l0 mM Tris.HO, pH 7.5, 2 mM 
EDTA, and precipitated with ethanol an additional two times. Yeast strain 
SEY2102 was transformed with mutagenized DNA by the lithium acetate 
procedure (35). Each petri plate (containing minimal medium without uracil) 
was spread with cells exposed to 2 #g of DNA. 
Individual transformants were spotted onto selective plates (minimal me- 
dium without uracil) and screened for invertase secretion by one or both of 
two methods. The first screen involved a qualitative assay of invertase on a 
filter paper disk. Plates of 100 transformants were stamped in duplicate onto 
plates containing YP medium (no glucose) and incubated at room temperature 
for 3-4 h during which time invertase synthesis was derepressed. One of each 
pair of plates was inverted over a chloroform-soaked paper towel for l0 min. 
Whatman No. 1 filter disks (Whatman Laboratory Products Inc., Clifton, N J) 
were bathed in a 2-ml solution that contained the invertase assay reagents: 0.l 
M sodium acetate, pH 5.1, 0.125 M sucrose, 0.4 mM N-ethylmaleimide, l0
~g/ml peroxidase, 0.6 mg/ml o-dianisidine, and 0.05 mg/ml glucose oxidase. 
Chloroform-treated and untreated copies of the transformants were stamped 
onto damp filters. Within a few minutes at room temperature, a pink color 
developed over most of the patches. This procedure was used to identify mutant 
suc2-sl, which showed more intense staining in the chloroform-treated r plica, 
but did not give sufficient resolution to detect he other mutants. 
The other screening procedure involved analysis of intracellular invertase 
activity by electrophoresis onnondenaturing polyacrylamide g ls. Cultures (5 
ml) of individual transformants were grown to mid-logarithmic phase in 
minimal medium + 5% glucose. A mixture of I ODr0o unit of cells from each 
of five cultures were centrifuged, washed with water, and incubated in minimal 
medium and 0.1% glucose for 3 h at 25"C. Cells were then washed with l0 
mM sodium azide, and l ODt,~o was resuspended in 0. l ml of 1.4 M sorbitol, 
50 mM potassium phosphate, pH 7.5, 10 mM sodium azide, 80 mM 2- 
mereaptoethanol, and 50 U oflyticase. After 60 min at 30"C, spheroplasts that 
sedimented at 3,000 g for l0 rain were lysed by resuspension i 50 mM 
potassium phosphate, pH 7.5, l0 mM sodium azide, 0.1% Triton X-100. An 
aliquot corresponding to0.15 OD~o0 unit of cells was electrophoresed on a 5% 
polyacrylamide slab gel using a system described by Meyer and Motile (36) 
except without SDS. lnvertase was localized in the gel, after incubation at 25"C 
for 20-60 min in 0. l M sodium acetate (pH 5.0), 0. l M sucrose, by the method 
of Gabriel and Wang (37). Pools containing mixtures of wild-type and suc- 
transformants showed primarily the rapidly and discretely migrating cyto- 
plasmic invertase with faint staining in the region that contained glycosylated 
forms of invertase. In pools that showed more intense staining in this latter 
region, individual members were screened irectly for invertase secretion and 
accumulation by the assay of Goldstein and Lampen (33) with minor modifi- 
cations (38). A unit ofinvertase will release l #tool of glucose from sucrose per 
minute at 25"C. 
Labeling, Immunoprecipitation, and Endo H Treatment: 
Cells were grown to mid-logarithmic phase in minimal medium + 5% glucose 
and 0.1 mM ammonium sulfate. 10Dr0o unit of cells was centrifuged, washed 
with water, and resuspended in fresh minimal medium + 0.1% glucose and no 
sulfate at l to 20D~o units ofcells/ml. These conditions allowed erepression 
of invertase synthesis. After 20 min at 25"C, 250 #Ci of carrier-f~ H23sSO4 
was added and cultures were incubated an additional 30 min. Labeled cells 
were washed and converted to spheroplasts a described in the previous ection. 
Spheroplasts were centrifuged, the supernatant fractions were adjusted to 0.5% 
SDS, and the pellets were resuspeoded in 50 t~l of 1% SDS. Samples were 
heated in boiling water for 3 min, diluted to l ml with PBS and 2% Triton X- 
100, and treated with 25-50 ~l of IgG Sorb, prepared as described by the 
manufacturer, for 30 rain at 0*C. IgG Sorb was removed by centrifugation at
12,000 g for 20 rain and supernatant fractions were transferred to new micro- 
fuge tubes. Antibody was added (invertase serum, 4 #l/OD~o unit cell equiva- 
lent; acid phosphatase rum, 4 #l/ODr0o until cell equivalent for spheroplasts, 
and 100 t~l/ODt, oo unit cell equivalent for spheroplast upernatant fractions) 
and samples were incubated at 0*C for 2 h. Invertase immunoprecipitafion 
samples were supplemented with 125 #l (4-5 mg protein) of nonradioactive 
extract from strain SEY2102; this served to compete for precipitation of 
unrelated proteins. IgG Sorb was added at 10-20 ul per l #l of serum, and 
immune complexes formed during 30 min at 0*C were sedimented at12,000 g
for l min. Complexes were washed twice with 0.5 ml of 2 M urea, 0.2 M 
sodium chloride, 0.1 M Tris.HCl, pH 7.5, 1% Triton X-100, and then twice 
with 0.5 ml of 1% 2-mereaptoethanol. Final pellets were resuspended in 25-50 
#l of sample buffer (50 mM Tris.HCl, pH 6.8, 10% glycerol, 1% SDS, 2% 2- 
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mercaptoethanol, 0.01% bromphenol b ue) and heated in boiling water for 3 
rain. After centrifugation i a microfuge for 5 min, the supernatant fractions 
were subjected to gel electrophoresis on 6% SDS polyacrylamide slab gels 
according to the procedure of Laemmli (39). Gels were fixed, in some cases 
prepared for fluorography with ENHANCE, dried, and allowed to expose 
Kodak X-Omat AR film at -70"C. Autoradiograms were quantified by scan- 
ning with an E-C Apparatus Corp. (St. Petersburg, FL) EC910 densitometer 
tracer. 
Modifications of the standard procedure were used in certain experiments. 
In the kinetic analysis, cells were incubated with H23sSO4 at 10D60o unit/ml 
for 5 min (or 10 min for labeling of acid phosphatase). Cultures were then 
adjusted to 0.5% glucose, 1 mM ammonium sulfate, 100 #g/ml cycloheximide, 
to initiate the chase period. Aliquots of 1 ODin unit of cells were taken at 
various times and added to chilled tubes that contained 10 #1 of 1 M sodium 
azide. Cells were washed once with cold 10 mM sodium azide and held at 0°C 
until the conclusion of the experiment. In the experiment in which acid 
phosphatase and invertase were both evaluated, samples were split and one- 
half of each was treated with the respective antiserum. 
For treatment with endo H, aliquots of immunoprecipitated invertase, after 
solubilization in sample buffer and separation from IgG Sorb, were diluted 
twofold and adjusted to 0.1 mg/ml BSA, 0.1 M sodium'acetate, pH 5.1. 
Samples were incubated with 0.5 mU ofendo H overnight at 37"C. After being 
heated in boiling water, samples were subjected to SDS gel electrophoresis. 
N-Terminal Analysis of Mutant and Wild-type Inver- 
tase: For N-terminal analysis of secreted invertase, strain SEY2102 contain- 
ing pRB58 with either SUC2 or the sl mutant was derepressed for invertase 
synthesis (40D6oo units of cells) in 2 ml of minimal medium with no sulfate 
and 0. 1% glucose. After l0 min at 25"C, 2 mCi of H23SSO4 were added to each 
sample for 60 rain at 25"C, and a chase period was initiated as described earlier 
for the kinetic analysis. Cells were centrifuged after a 60-rain chase period, 
washed with l0 mM sodium azide, and converted to spheroplasts. Invertase in 
the E fraction was immunoprecipitated as escribed earlier, using anti-invertase 
antibody that had been afffinity-purified by adsorption to and elution from 
cytoplasmic nvertase-conjugated to Sepharose 4B. The precipitates were solu- 
bilized in 30 td of sample buffer and separated from IgG Sorb by centrifugation; 
l ul of each was subjected to SDS gel electrophoresis to confirm the purity of 
the labeled samples. The remaining samples were extracted twice with l ml 
acetone/triethylamine/acetic acid (90:5:5) and then three times with acetone. 
Each extraction was incubated for 20 min at 0*C and then centrifuged at12,000 
g for 10 rain. The final pellets were resuspended in 50 #l of l0 mM ammonium 
bicarbonate, 0.02% SDS. Samples were subjected to sequential Edman degra- 
dation using an Applied Biosystems (Foster City, CA) 470A gas-phase protein 
sequencer. Material released in each of the first 15 cycles was measured for 3SS 
counts per minute. 
For N-terminal analysis of ER-localized invertase, 5 ODin units ofSEY5188 
(secl8) containing pRB58 with either wild-type or sl mutant SUC2 genes were 
transferred to l ml of minimal medium with 0. 1% glucose, no sulfate, and 4 
~M leucine. After 10 min at 25"C, 250 #Ci of [SH]leucine and 2 mCi H235SO4 
were added to each sample. Cells were incubated for 60 rain at 37"C, washed 
with 10 mM sodium azide, and converted to spheroplasts. Spheroplast pellet 
fractions were lysed, and invertase was immunoprecipitated with afffinity- 
purified antibody and treated with endo H as described earlier. Samples were 
subjected to SDS gel electrophoresis ona 6% polyacrylamide g l that had been 
polymerized overnight and prerun for 5 min. The gel was dried without fixation 
and subjected to autoradiography. Protein bands of interest were excised from 
the gel and electroeluted into dialysis tubing overnight at 4"C in 0.1 mM Tris- 
HCI, pH 8.0, 0.1% SDS, 0.1 mM sodium thioglycolate. Electroeluted samples 
were lyophilized to dryness and extracted twice with acetone/triethylamine/ 
acetic acid/water (88:5:5:2) and three times with acetone as described earlier. 
The final pellets were resuspended in 10 mM ammonium bicarbonate, 0.02% 
SDS. Samples were subjected to sequential Edman degradation, and 15 cycles 
were counted for 35S and 3H. in the samples of wild-type invertase, ~35,000 
cpm of 3sS was released at the indicated cycle and ~2,000 cpm of 3H was 
released, sl mutant invertase samples released -16,000 cpm of ~S at the 
indicated cycle, and 1,000-1,500 cpm of SH was released at each of the indicated 
cycles. 
Release of Invertase by Saponin: To test the solubility of the 
accumulated invertases, 50 ODin units of SEY2102 cells, containing an inte- 
grated copy of either SUC2-sl or SUC2-s2, and SEY5186 (sec18 SUC2) were 
collected by centrifugation and washed once with water. Cells were resuspended 
in 50 ml of minimal medium and 0.1% glucose. After 2 h at 37°C, 50 ODin 
units were collected by centrifugation, washed with 10 mM sodium azide, and 
converted to spheroplasts a  described earlier, except at 50 ODt,0o U/ml and 
with 5,000 U/ml of lyticase. After 60 min incubation at 30"C, spheroplasts 
were collected by centrifugation for 5 rain at 3,000 g and washed once with 
spheroplast buffer without lyticase and 2-mercaptoethanol. Spheroplasts were 
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then lysed in 50 mM KHaPO4, pH 7.5, 10 mM NuNs, a treatment that retained 
~80% of wild-type invertase in sec18 in a latent, sedimentable form. Aliquots 
of the lysed spheroplasts were adjusted to a range of saponin concentrations, 
incubated at 4"C for 60 rain, and then centrifuged at 133,000 g for 12 min in 
a Beckman airfuge (Beckman Instruments, Inc., Pulp Alto, CA) with an A100 
fixed-angle rotor. Supernatant fractions were removed and saved. Pellet frac- 
tions were resuspended to the original volume in 50 mM KH2PO4, pH 7.5, 10 
mM NAN3, 0.1% Triton X-100. Fractions were assayed for protein concentra- 
tion, invertase activity, and cytochrome c reductase activity according to 
published procedures (protein [40], invertase [33], cytochrome c reductase 
[41]). 
Recombinant DNA and Marker Rescue Mapping: Plasmid 
purification, agarose gel electrophoresis, transformation of bacteria, and other 
DNA manipulations were performed by standard methods (42). 
Wild-type, sl, and s2 SUC2 genes were subcloned into YIp5 (30) by ligation 
of a 4.5 base pair XhoI to Clal fragment of the SUC2 insert into YIp5 cut with 
Sail and Clal. Uncut Ylp5 containing wild-type and mutant SUC2 genes were 
then transformed into SEY2102. URA ÷ transformants re ulting from integra- 
tion of YIp5 into the genome were picked and assayed for invertase secretion. 
For construction of mutant-wild type hybrid genes, SUC2 was first subcloned 
by inserting the HindIlI fragment of oRB58 into the unique Hindlll site of 
pSEY8 (see Fig. 6). The 800 base EcoRI-BamHl fragment in this pSEY8 
construct was then replaced with the 1,600 base EcoRI-BamH 1fragment of 
SUC2-sl, -s2, or -s3 from mutant pRB58 plasmids. Hybrids then contained 
the 5' half of a mutant gene and the 3' half of wild-type SUC2. 
For marker escue mapping, SUC2-sl, -s2, and -s3 HindIlI fragments were 
subcloned into the pSEY8 HindlIl cloning site, and the resulting plasmids were 
introduced into yeast strain SEY2102 (a SUC2-A9). SEY2102 (a SUC2-A9) was 
transformed with the SUC2-1acZ fusion vectors pSEYI25, oSEYI24, and 
pSEYI22 (29). Strains were mated pairwise on YPD plates, and after 1-2 d the 
mating patches were resuspended in water and spread on minimal medium 
plates +2% sucrose, 0.02 mg/ml ergosterol, 0.25 mg/ml oleate, 2.5 mg/ml 
Tergitol Nonidet P-40, and 20 #g/ml uracil. Plates were incubated at 30"C in 
an anaerobic jar using the BBL-Gas Pak anaerobic system. These conditions 
allowed growth only ofSUC* recombinants that were picked after 5-6 d. SUC ÷ 
colonies were streaked on fresh plates and grown selectively for an additional 
4 d. Single colonies representing a number of original recombinants were grown 
in liquid medium, and secretion and accumulation of invertase were assessed 
as before. 
DNA Sequencing: Preparations ofeach of the mutant SUC2 plasmids 
were digested with BamH 1 and Hindlll. The 776 base fragment that contained 
the 5' half of each mutant SUC2 gene was purified by gel electrophoresis in 
and extraction from low melting temperature agarose (43). M I3 rap8 or M I3 
mp9 RF (replicative form) DNA was digested with HindliI and BamH 1, and 
30 ng of this DNA was reacted with 200 ng of the SUC2 purified fragment in 
the presence of T4 DNA ligase. Ligated DNA was used to transfect E. coli 
JMI03 (44). Single-stranded DNA was isolated from cultures grown from 
individual recombinant phage plaques and used as template for DNA sequenc- 
ing by the dideoxy chain termination technique (45). M I3 mp8 and M I3 rap9 
have Hindlll and BamHl cloning sites in opposite orientations. M13 rap8 
provided coding strand sequence for about 450 bases from the Hindlll site in 
the signal sequence coding region, while M I3 rap9 provided 450 base pairs of 
sequence on the noncoding strand from the BamHl site in the middle of the 
SUC2 gene. 
RESULTS 
Mutagenesis of Cloned SUC2 Gene 
A 2 ~ yeast plasmid containing the SUC2 gene and a 
selectable marker gene (URA3) was mutagenized in vitro with 
hydroxylamine which produces C to T transitions. Mutant 
DNA was introduced by transformation i to a ura3 strain 
that contained a deletion in the SUC2 gene (28). Hydroxyl- 
amine treatment was adjusted so that 10-15 % of the plasmids 
that were recovered by transformation contained SUC2 mu- 
tations resulting in no active invertase. The efficiency of 
transformation byDNA mutagenized at this level was reduced 
twofold for yeast and 104-fold for E. coil 
In a sampling of 60 independent suc- mutants, 31 failed to 
make any invertase immunoreactive protein, which, in most 
cases, was due to major rearrangements in the plasmid DNA. 
Of the remaining 29 mutants in which immunoreactive ma- 
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terial was detected, six produced forms with electrophoretic 
mobilities characteristic of invertase accumulated in the en- 
doplasmic reticulum (46). These mutations may produce 
denatured forms ofinvertase that can not be transported from 
the ER. 
To identify mutations that affect ransport but not correct 
folding of the invertase polypeptide, we screened 6,000 inde- 
pendent transformants byprocedures that detect intracellular 
accumulation of active invertase. Four were found that fit 
this criterion, and the extent of invertase accumulation is
shown in Table I. Cells transformed with the normal or 
mutant (SUC2-s I to -s4) plasmids were derepressed for inver- 
tase synthesis, converted to spheroplasts, and the released 
(periplasmic) and sedimentable (intracellular) activity was 
measured. With the exception of mutant s4, nearly normal 
levels of invertase were produced (Table I, lines 1-5). All of 
the mutants howed at least fivefold accumulation of intra- 
cellular invertase, with sl the most dramatic at 30-fold. In- 
vertase derepressed under steady-state conditions of growth, 
in raffinose, showed the same accumulation behavior (Table 
I, lines 6-8). Despite the reduced rate of invertase transport, 
cells carrying the mutant plasmids grew normally on sucrose- 
selective medium. 
Cytoplasmic nvertase, a nonsecreted protein product of an 
alternative SUC2 transcript (26), was examined by electro- 
phoresis of spheroplast extracts on a nondenaturing gel sys- 
tem. Mutants 1, s2, and s3 produced normal amounts of this 
enzyme (not shown). Mutant s4 was eliminated from further 
consideration because the low amount of periplasmic inver- 
tase produced was less stable and cytoplasmic nvertase was 
inactive. 
Cells transformed with the multicopy SUC2 plasmid pro- 
duced about 10-fold more invertase than was detected in 
normal cells with a single-chromosomal SUC2 gene. To test 
whether overproduction f the mutant invertase contributed 
to the secretion-defective phenotype, SUC2 mutant genes 
were subcloned into the integrating plasmid YIp5 and recom- 
bined into the yeast genome. Whereas the amount ofinvertase 
dropped 10-fold, the extent of accumulation was unaffected 
(Table I, lines 9-11). These results also showed that the 
mutations were linked to SUC2. 
Mutants Defective in Transport of Core- 
glycosylated Invertase 
Invertase transport intermediates have been identified in 
pleiotropic sec mutants that are blocked at successive stages 
in the secretory pathway. Mutants such as secl8, in which 
transport from the ER to the Golgi body is blocked, represent 
the earliest stage where an active secretory form of invertase 
is detected. SDS gel electrophoresis of invertase accumulated 
in secl8 reveals several discrete species of around 80 kd, 
corresponding to core-glycosylated molecules. Subsequent ol- 
igosaccharide modifications in the Golgi body produces het- 
erogeneous, low electrophoretic mobility forms of invertase 
(46). 
To identify the site of accumulation of mutant invertase, 
we labeled cells (wild type and secl8) transformed with plas- 
mids carrying wild-type, SUC2-sl, -s2, or -s3 mutant genes 
for 30 rain with 35SO42-, converted them to spheroplasts, and 
evaluated the periplasmic (external, E) and intracellular (I) 
fractions by immune precipitation and SDS gel electropho- 
TABLE I 
Accumulation of Active Invertase in SUC2 Mutants 
Derepressed 
intracellular Periplasmic Fold 
Line Plasmid/SUC2 type invertase* invertase Total activity accumulation* 
UnitsIOD cells % wild type 
1 pRB58/SUC2 0.40 1.71 100 1 
2 pR B58/SUC2-s 1 1.96 0.28 106 30 
3 pRB58/SUC2-s2 1.12 0.76 89 6.7 
4 pRB58/SUC2-s3 1.13 0.87 95 5.7 
5 pRB58/SUC2-s4 0.52 0.43 45 5.2 
6 pRB58/SUC2 0.04 0.77 I00 1 
7 pRB5815UC2-s1 0.60 0.35 117 34 
8 pRB58]SUC2-s2 O. 16 0.53 85 6 
9 YIp5ISUC2 0.03 0.29 100 1 
I0 YIp5]SUC2-sl 0.15 0.05 63 33 
11 YIp5/SUC2-s2 0.27 0.22 150 12 
12 s SUC-sl 0.74 O. 12 62 36 
pRB58/Eco-Barn hybrid 
13 SUC2-s2 0.71 0.90 116 6 
pRB58/Eco-Bam hybrid 
14 SUC2-s3 0.55 0.83 99 5.1 
pRB58/ E_co-Bam hybrid 
* SEY2102 was transformed with the indicated plasmids. Except in the experiment in lines 6-8, cells were grown to mid-log phase in selective minimal medium 
and 5% glucose, washed, and derepressed for 3-4 h at 25°C in minimal medium and O.1% glucose. Cells were converted to spheroplasts and centrifuged, 
and the supernatant (periplasmic) and pellet (intracellular) fractions were assayed for invertase activity. A constant background of cytoplasmic invertase activity 
was subtracted to give the derepressed intracellular level. Cells in the experiment in lines 6-8 were grown in minimal medium and 2% raffinose. 
The ratio of derepressed intracellular to periplasmic activity for mutant SUC2 alleles divided by the ratio for wild-type SUEZ 
! Results of a separate xperiment with values normalized to assays of pRBS8/SUC2 done in parallel. 
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resis. After this labeling period in wild-type cells containing 
pRB58, the cytoplasmic nvertase and some of the ER transit 
form were found in the I fraction, while much of the invertase 
was highly glycosylated and in the E fraction (Fig. l). The ER 
transit forms accumulated in secl8 were similar to those 
found in wild-type cells. SUC2-sl, -s2, and -s3 produced 
nearly exclusively ER transit forms of invertase. Mutant sl 
(and s2, not shown) showed the same behavior when inte- 
grated into the chromosome (single copy). Unlike the pleio- 
tropic sec mutants, the SUC2 transport mutants were blocked 
to the same extent at 25 ° and 37"C (not shown). Hence, by 
comparison with the behavior of seclS, the SUC2 mutants 
appear to be nonconditionally defective in transport from the 
ER, or possibly from a compartment between the ER and the 
site of outer chain carbohydrate addition. 
In experiments with longer radiolabeling periods, highly 
glycosylated, secreted invertase was detected in cells that 
contained the sl, s2, and s3 mutant alleles. The possibility 
that these mutants were not absolutely defective in transport 
allowed additional definition of the stage in the pathway and 
of the specificity of the defects. 
If the transport-defective in rtase is delayed in the secre- 
tory pathway before or concurrent with the SEC18 dependent 
step, then invertase that accumulates at 25"C will not progress 
beyond the secl8 block at 37"C. On the other hand, if mutant 
invertase isdelayed beyond the SECI8 step, progress will not 
be hindered in secl8 cells at 37"C. secl8 cells, transformed 
with a plasmid carrying SUC2-s3, were labeled with 35SO42- 
for l0 min at 24"C (sec permissive temperature). Culture 
aliquots were subsequently incubated for 30 and 60 rain at 
24* and 37"C (sec nonpermissive t mperature) in the presence 
of cycloheximide. Intracellular and external invertase was 
examined by immunoprecipitation (Fig. 2). After the pulse, 
only core-glycosylated invertase in the I fraction was observed. 
With increasing chase time at 24"C, heterogeneous glycosy- 
lated material was detected in the E fraction, with a corre- 
sponding decline in core-glycosylated protein in the I fraction. 
No further glycosylation or secretion was seen when the chase 
was conducted at 37"C. This pattern was qualitatively similar 
in mutants l and s2, suggesting that all the invertase defects 
delay transport before or at the SEC18 step. Control experi- 
ments with wild-type cells containing mutant invertase 
showed secretion f about one-half of the sl invertase, and 
all of the s2 mutant protein, during the 60-min chase at 37"C. 
Differences among the invertase mutants were uncovered 
by a more detailed analysis of the kinetics of secretion at 
24"C. Ceils that carried plasmids with wild-type, sl, or s2 
invertase were pulse-labeled for 5 min. At various times during 
subsequent incubation in the presence of cycloheximide, sam- 
ples were withdrawn and the distribution of immunoreactive 
forms of invertase was evaluated. Fig. 3 shows the percentage 
of radiolabeled invertase (open symbols, core glycosylated; 
closed symbols, heterogeneous forms) thatremained intracel- 
lular at he indicated times of chase. In the pulse label, 60% 
of the wild-type invertase was core glycosylated and intracel- 
lular, whereas the highly glycosylated material was equally 
divided between intracellular and secreted. Conversion of 
core- to highly-glycosylated invertase occurred with a lj/2 of 
~1.5 min for the wild-type, -75 min for mutant sl, and -10 
rain for mutant s2 (same as s3, not shown). A semilogarithmic 
plot of the data for the mutants revealed a single kinetic 
constant for conversion of invertase. In each case, the total 
amount of labeled invertase remained constant during the 
chase period. A transient increase in highly glycosylated intra- 
cellular invertase was seen early in the chase period of wild- 
type protein, while mutant sl and s2 showed negligible intra- 
cellular levels of this form. These results uggest that mutants 
s 1 and s2 are distinct, and that secretion isspecifically delayed 
in the ER with no observable effect on subsequent transport 
from the Golgi body. 
Additional evidence for the specificity of the invertase 
mutations came from an analysis of acid phosphatase cre- 
tion and growth rates of strains that contained the mutant 
SUC2 plasmids. A strain that carries the pho80-2 mutation, 
and therefore constitutively makes and secretes acid phospha- 
tase (47), was transformed with wild-type or mutant SUC2 
plasmids. Cells were derepressed for invertase xpression and 
labeled for l0 min at 25"C, and samples were withdrawn at 
intervals during a chase in the presence of cycloheximide. The 
distribution of radiolabeled forms of acid phosphatase was 
FIGURES 1 Immunoprecipitation a d electrophoresis of wild-type and mutant invertases. SEY2102 cells transformed with pRB58 
containing either wild-type or mutant SUC2 genes and SEY5188 (secl8) containing pRB58 were derepressed for invertase 
expression and labeled with 3sSO42- for 30 min. Samples were separated into spheroplast pellet (/) and spheroplast supernatant 
(E) fractions and immunoprecipitated with invertase antiserum. Immunoprecipitates were analyzed by SDS PAGE and autora- 
diography, mature, highly glycosylated invertase; ER, core-glycosylated invertase characteristic of endoplasmic reticulum forms' 
cyto, cytoplasmic invertase. 
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FIGURE 2 Secretion of s3 mutant 
invertase blocked in secl8 at 
37*C. SEY5188 (secl8) cells trans- 
formed with pRB58 that con- 
tained SUC2-s3 were derepressed 
for invertase expression and la- 
beled with ssso42- for 10 min at 
25"C. Immediately after initiation 
of the chase period by addition 
of glucose, unlabeled sulfate, and 
cycloheximide, an aliquot of the 
culture was transferred to 37°C 
and the rest was kept at 25"C. 
Aliquots were taken at various 
times, separated into spheroplast 
pellet (I) and spheroplast super- 
natant (E) fractions, and immu- 
noprecipitated with invertase 
antiserum. Immunoprecipitates 
were analyzed by SDS PAGE and 
autoradiography. 
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FIGURE 3 Kinetics of wild-type and mutant invertase secretion. 
5EY2102 cells that contained either the wild-type or s2 mutant 
SUC2 genes were derepressed for invertase expression and labeled 
for 5 rain with 35SO42-. Chase was initiated with the addition of 
glucose, unlabeled sulfate, and cycloheximide. Aliquots were taken 
at various times, separated into spheroplast pellet and supernatant 
fractions, and immunoprecipitated with invertase antiserum. Im- 
munoprecipitates were subjected to SDS PAGE and fluorography. 
Cross-reacting material was quantified by densitometric scanning. 
evaluated by immunoprecipitation and SDS gel electropho- 
resis. As with invertase, acid phosphatase undergoes a core- 
to highly-glycosylated conversion after transport to the Golgi 
body (46). Core-glycosylated acid phosphatase was converted 
and secreted at the same rate in cells that were producing 
wild-type or mutant invertase (not shown). In the same sam- 
ples, the pattern of invertase glycosylation and secretion was 
identical to that seen in Fig. 3. Furthermore, the invertase 
mutants did not interfere with any essential spect of growth; 
doubling times in derepressing media were the same for cells 
carrying wild-type or SUC2 mutant plasmids. 
Physical Properties of the Mutant Invertases 
Delayed secretion of mutant invertase could be accounted 
for by aberrant subunit interaction or aggregation within the 
lumen of the ER. This possibility was tested by native gel 
electrophoresis of invertase released from membranes by 
treatment with Triton X-100. Secreted invertase, d tected 
with an activity stain, migrates as a heterogeneous mixture, 
whereas enzyme accumulated in the ER (such as in secl8) 
displays four discrete species which appear to be multimeric 
forms of the active dimer (46). For comparison, wild-type and 
sec18 cells containing SUC2, SUC2-sl (on a multicopy plas- 
mid or integrated), -s2, or -s3 were derepressed for invertase 
synthesis and fractionated as before. Fig. 4 shows the pattern 
described above for wild-type and sec18 cells. The intracellular 
enzyme produced by mutants s2 and s3 migrated as did 
invertase in sec18. Mutant s l, however, appeared aggregated 
with a heterogeneous and low electrophoretic mobility. A 
pattern more like that of secl8 was seen with cells that 
contained a single copy of mutant sl, although most of the 
invertase was concentrated in the lowest mobility forms. 
While Triton X-100 quantitatively released the ER-accu- 
mulated forms of invertase, at least one ER integral mem- 
brane protein, NADPH-cytochrome c reductase, was also 
solubilized. To address the issue of invertase solubility in the 
ER lumen, saponin, a detergent that permeabilizes but does 
not solubilize the ER membrane, was used to examine release 
of invertase activity from the membrane fraction. Sphero- 
plasts made from cells (wild type or sec18) that had accumu- 
lated normal or mutant invertase were osmotically lysed 
under conditions that retained invertase in a sedimentable, 
presumably ER-bounded form. Extracts were mixed with 
various amounts of saponin at 0*C, and the amounts of 
sedimentable protein, NADPH-cytochrome c reductase, and 
invertase were assessed. Fig. 5 shows that very little protein 
(top) and no NADPH cytochrome c reductase (middle) were 
solubilized by saponin concentrations a high as 0.6 mg/mg 
protein. Wild-type invertase accumulated in secl8 and s2 
mutant invertase were readily released (70-80% solubilized; 
Fig. 5, bottom) by saponin at 0.2-0.3 mg/mg protein. In 
contrast, only ~35% of the sl mutant invertase was released 
by saponin. S 1 mutant enzyme that resisted saponin extrac- 
tion was solubilized with 0.1% Triton X-100 and compared 
with the saponin-released invertase by native gel electropho- 
resis. Heterogeneous, low-mobility invertase was enriched in 
the saponin pellet fraction and discrete, higher-mobility forms 
were recovered in the saponin soluble fraction (not shown). 
Hence, by the native gel electrophoresis and saponin solubility 
criteria, sl mutant invertase appears to be aggregated and to 
some extent associated with the ER membrane, whereas the 
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FIGURE 4 Nondenaturing gel 
electrophoresis of wild-type and 
mutant invertase. SEY2102 cells 
containing either wild-type or 
mutant SUC2 genes and SEY5188 
(seclS) cells containing the wild- 
type 5UC2 gene were dere- 
pressed for invertase expression 
for 3 h and separated into spher- 
oplast pellet (I) and spheroplast 
supernatant (E) fractions. Samples 
were subjected to nondenaturing 
gel electrophoresis, and the gel 
was stained for invertase activity. 
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FIGURE 5 Saponin solubilization of accumulated invertase. 
SEY2102 cells that contained the mutant SUC2 genes and SEY5188 
(seclS) cells with the wild-type 5UC2 gene were derepressed for 
invertase expression and converted to spheroplasts. Sedimented 
spheroplasts were lysed by osmotic shock. Aliquots were treated 
with different saponin concentrations and centrigued at 133,000 g. 
Pellet and supernatant fractions were assayed for invertase activity 
(bottom), NADPH-cytochrome c reductase activity (middle), and 
total protein (top). Values represent the fraction sedimentable rel- 
ative to the no detergent control. O, seclS; O, SUC2-sl; A, SUC2- 
s2. 
s2 mutant enzyme is indistinguishable from normal invertase 
accumulated in the ER lumen, s2 and s3 mutant enzymes 
were identical in these characteristics. In other experiments, 
the mutant invertases had heat stability properties similar to 
those of the wild-type nzyme. 
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Mapping and Sequencing the SUC2 Mutations 
Since the SUC2 mutants were derived from DNA that was 
heavily mutagenized, it was likely that the isolates contained 
multiple mutations. For this reason, it was essential to localize 
the phenotypically important mutations by genetic mapping. 
We localized the transport-deficient mutations to the 5' 
half of SUC2 by subcloning a 1,600 base pair EcoR 1-BamH 1 
fragment from the mutant DNA, containing about 770 bases 
of the 5' coding region, into a vector that contained the 3' 
half of wild-type SUC2. Donor and recipient plasmids are 
diagrammed in Fig. 6. Yeast transformants hat contained 
the hybrid constructs showed the same invertase accumula- 
tion phenotype of the parents (Table I, lines 12-14). The 
accumulated material was examined by nondenaturing and 
SDS gel electrophoresis, and with one minor exception, the 
original phenotypes were reproduced. In the original sl iso- 
late, cytoplasmic nvertase migrated more slowly than normal 
on a nondenaturing gel (Fig. 4). The EcoRI-BamHl hybrid 
of mutant sl produced a normal cytoplasmic nvertase (not 
shown), suggesting that the 3' half of the original isolate 
contained at least one additional mutation that had no de- 
tectable influence on invertase transport. 
To localize the transport mutations more precisely within 
the 5' coding region, we devised a form of marker escue 
recombinant analysis. HindlII fragments from plasmids car- 
rying SUC2-sl, -s2, and -s3 were subcloned into the HindlII 
site of pSEY8 (Fig. 6). These constructs were missing the 5' 
regulatory sequences and the first 10 bases coding for the 
secreted form of invertase. Cells transformed with these plas- 
mids were mated with cells carrying another plasmid that 
contained one of a series of gene fusions in which a portion 
of the wild-type SUC2 5' regulatory and coding sequence was 
fused to a nearly full-length fragment of the E. coli lacZ gene 
(29). Neither construct allowed invertase synthesis; conse- 
quently, anaerobic growth of diploid strains on sucrose pro- 
vided a selection for recombinants hat generated functional 
invertase. Since the presence of even the sl mutant invertase 
allowed growth on sucrose, wild-type and transport-deficient 
recombinants were generated. Wild-type recombinants could 
be generated only if the region containing the transport mu- 
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Plasmids for hybrid SUC2 mapping, pRB58 contained the SUC2 gene and pSEY8 provided a region with many 
convenient restriction sites. H, Hindlll; R, EcoR1; B, BamH1; X, Smal; S, Sail; P, Pstl. 
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FIGURE 7 Marker rescue recombinational mapping of SUC2 mutants. The strategy for recombinational mapping of the SUC2 
mutations is outlined. Plasmids carried either a 5UC2-/acZ fusion (top) or a 5'-truncated mutant SUC2 gene (bottom). A, t3, and C 
are hypothetical mutations and the long arrow between the two plasmids is one possible SUC2 + recombinant. 
tation was represented on the SUC2 lacZ fusion. The ratio of 
wild-type and mutant recombinants was an approximate mea- 
sure of the position of the mutation within the region of 
homology. This point is illustrated in Fig. 7: Mutations in 
region A would give mainly wild-type recombinants, in B 
would yield a mixture of mutant and wild-type, and in C 
would produce only mutant recombinants. Fig. 8 presents 
data on the percentage of wild-type recombinants generated 
in crosses between each mutant and hybrid genes that con- 
tained 150, 600, or 800 bases of SUC2. Mutant sl showed a 
high percentage of wild-type recombinants even with the 
smallest SUC2 fusion tested. Mutants 2 and s3 showed wild- 
type recombinants only with the next larger SUC2 fusion. 
The possibility that transport mutations are 5' to the HindlII 
site in the coding sequence is eliminated by these data. Ap- 
proximate map positions for these mutations are indicated in 
Fig. 8. Additional mutations required for the transport defect 
could reside between the marker escue site and the BamH 1 
site in the middle of the gene. 
The transport mutations were defined precisely by DNA 
sequence analysis of the 776 base HindlII-BamH 1 fragment 
from each mutant plasmid. SUC2-sl contained two muta- 
tions in this region. One silent mutation resulted in exchange 
ofphe codons at amino acid position 150 (TTC to TTT). The 
important mutation produced a change in the final codon of 
the signal peptide from ala to vat (GCA to GTA). Although 
SUC2-s2 and -s3 mutations were derived from separate sam- 
ples of mutagenized DNA, they both contained the same 
single substitution resulting in ile in place of thr (ACT to 
ATT) at position +64 in mature invertase. Two segments of 
the invertase protein sequence in the area of mutations sl and 
s2 are shown in Fig. 9. A close correspondence was found 
between the map position determined by marker escue re- 
combinant analysis and DNA sequencing of the mutations. 
Signal Peptide Processing of Mutant Invertase 
Secreted invertase is processed from a precursor that con- 
tains a 19 amino acid signal peptide (48). Since valine is not 
found on the N-terminal side of signal peptide cleavage sites 
(49), SUC2-sl mutant invertase could be defective in cleavage 
by signal peptidase. Retention of the signal peptide on mutant 
invertase was assessed by treatment of accumulated and se- 
creted material with endo H. sec18 and wild-type cells con- 
taining the SUC2, -s l, or -s2 plasmids were radiolabeled with 
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SUC2-sI SUC2"s2 SUCZ's3 
pSEY I25  80%wt O%wt 0% wt 
(150bp) (40) (47) (36) 
pSEYI24 too% wt ~9o% wt ~7o% wt 
(600 bp) (12) (28) (30) 
p(SEY122 100% wt 100% wt N.D. 
800bpl (5) (2) 
sl s2,s3 
- /  > 
FIGURE 8 Mutations map to a region of <_250 
base pairs at the 5' end of the SUC2 gene. 
SEY2102 cells containing 5' truncated con- 
structs of the mutant SUC2 genes were mated 
with SEY2101 containing three different size 
classes of SUC2-1acZ fusions. PSEY125 con- 
tained 150 bases, pSEY124 contained 600 
bases, and pSEY122 contained 800 bases of 
5UC2 coding sequence. The table gives the 
percentage of wild-type recombinants from 
each cross. The number in parenthesis is the 
number of recombinants analyzed for each 
cross. The sketch shows the approximate po- 
sitions of the mutations predicted by the map- 
ping data. 
I = I 
0 0.2 
, I ~ I , I L I ~ I i 1 = I 
~4  0 .6  0 .8  1.0 1 .2  1.4 1 .6  
Kb  
SUC2 
SUC2 
SUC2-sl 
signal 
cleavage 
-19 -I0 ~ 1 
Met-•eu-•eu-gln-ala-phe-leu-phe-leu-leu-ala-gly-phe-ala-ala-lys-ile-ser-ala-ser-met••• 
val 
60 70 
SUC2 . . .g ly -h is -a la - thr -ser -asp-asp- leu- thr -asn- t rp-g lu-asp-g ln-pro- i le . . .  
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FIGURE 9 Amino acid changesin SUC2transport mutants. 
355042- for 30 min and converted to spheroplasts, and the I 
and E fractions were treated with invertase antibody. Samples 
of the immunoprecipitates were treated with endo H under 
conditions where all the oligosaccharides are cleaved from 
invertase. Untreated and deglycosylated invertase samples 
were compared by SDS gel electrophoresis. Endo H treatment 
produced a form with an apparent Mr of 58,500 for normal 
invertase accumulated in secl8, and s2 invertase in normal 
cells (Fig. 10). The difference of-2.5 kd between this species 
and the cytoplasmic nvertase was expected from the 10-12 
GIcNAc residues that remain after endo H treatment. Two 
forms of deglycosylated sl invertase of approximately equal 
abundance were seen in the I fraction. One was the 58.5-kd 
species and the other was a 61-kd form corresponding to an 
increment expected for retention of the signal peptide. The 
same 2.5-kd size difference was seen in a comparison of 
unglycosylated s 1 and wild-type invertase produced in tuni- 
camycin-treated cells (not shown). By this criterion, signal 
peptide processing was normal for mutant s2 but defective for 
sl mutant invertase. 
After a chase period of 2 h, invertase secreted in mutant sl 
1672 THE JOURNAL OF CELL BIOLOGY . VOLUME 100, 1985 
was in the usual highly glycosylated form. Only the 58.5-kd 
species was detected when this material was treated with endo 
H (Fig. 10). Since the immunoreactive invertase was re- 
covered in good yield after the chase period, some of the 
glycosylated precursor must have been proteolyticaUy proc- 
essed en route to the periplasm. 
To confirm the accumulation ofunprocessed invertase, and 
to determine the site of cleavage of the mutant protein, we 
performed sequential Edman degradation of 35SO42--[3H]leu - 
cine double-labeled proteins. Wild-type forms of invertase 
accumulated in sec18, or secreted in a wild-type strain, were 
removed from SDS gels of samples that had been treated with 
endo H. Table II shows that 35S was released in the second 
cycle of Edman degradation and 3H was released in cycle 11. 
This was expected from the location of met and leu in mature 
invertase at position 2 and 1 1, respectively, sl invertase that 
accumulated in a wild-type cell in the apparently unprocessed 
and processed forms were compared with the mutant secreted 
form by the same analysis. As expected from the sequence of 
the gene, 35S was released from the unprocessed form in cycle 
1, and 3H in cycles 2, 3, 7, 9, and 10. In contrast to wild-type 
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FIGURE 10 Endo H treatment of 
wild-type and mutant invertases. 
S EY5188 (secl8) transformed with 
the SUC2 plasmid and SEY2102 
transformed with mutant plas- 
mids were derepressed for inver- 
tase expression and labeled with 
35SO42- for 30 min (37°C for 
SEY5188 and 25°C for SEY2102). 
A portion of the SEY2102 culture 
was incubated an additional 2 h 
under conditions of chase. Spher- 
oplasts formed from each sample 
were sedimented, and invertase 
immunoprecipitated from the 
pellet (/} and supernatant (E) frac- 
tions as before. Samples of each 
were treated with endo H and 
compared with untreated mate- 
rial by SDS gel electrophoresis 
and autoradiography. 
TABLE II 
S 1 Signal Cleavage Occurs at an Alternate Site 
3sSO4 in 
cycle [3H]leu in cycle 
ER 2 11 
5UC2 
Secreted 2 ND 
SUC2-s 1 
ER-unprocessed 1 2, 3, 7, 9, 10 
ER-processed 1 10 
Secreted 1 ND 
1 2 3 7 9 10 
met-leu-leu-gln-ala-phe-leu-phe-leu-leu-ala-gly-phe-ala-ala-lys-ile- 
i 2/1 11/10 
ala ser-va I- ser- met-thr-asn-g[u-thr-ser-asp-arg-pro-leu 
T ? 
ND, not determined. 
* Normal cleavage site. 
* sl mutant cleavage site. 
processed invertase, 35S was released in cycle 1 of the processed 
mutant form, and 3H in cycle 10 of the accumulated form. 
Hence, the val-ser bond was not cleaved in sl mutant inver- 
tase; instead, the adjacent ser-met bond was cleaved at a 
reduced rate. 
DISCUSSION 
Lesions in a transport signal could, by means of genetic 
suppressor analysis, lead to the definition of interacting pro- 
teins that mediate transport. As a first step in this approach, 
we have designed a screening procedure to detect mutations 
in the invertase structural gene that specifically affect secre- 
tion. By insisting on retention of full enzyme activity, we 
should avoid mutations that simply result in denatured pro- 
tein precipitated in the lumen of a secretory organelle. As an 
illustration of this point, of 29 independent suc2 mutant 
isolates that produce enzymatically inactive invertase cross- 
reacting material, six were found to accumulate in a core- 
glycosylated form. These mutations most likely yield dena- 
tured invertase that remains in the ER. 
Starting with extensively mutagenized SUC2 plasmid DNA, 
only three out of 6,000 transformants were found that accu- 
mulate active, stable invertase. Of these, two contain the same 
mutation. The distinct mutations, SUC2-sl and -s2, produce 
fully active forms of invertase which are delayed in transport 
from the ER (or possibly some post-ER compartment) to the 
Golgi body, but not to a similar extent in subsequent export 
to the cell surface. This delay is considerably greater for sl 
than s2. 
Signal peptide cleavage in the sl mutant invertase is defi- 
cient owing to the substitution of val for ala at position - 1 of 
the cleavage site. Retention of the signal peptide on about 
half of the sl molecules causes invertase to form irregular 
assemblies, as detected by electrophoresis in a nondenaturing 
gel system. These assemblies remain associated with ER mem- 
branes permeabilized by a weak detergent, saponin, while 
being readily solubilized by Triton X-100. The other half of 
the accumulated sl invertase, which has a polypeptide size 
characteristic of the proteolytically processed form, may be 
retained by normal subunit association with the unprocessed 
subunits. Alternatively, as this material is processed at the 
adjacent peptide bond, met-terminated invertase may be in- 
herently transport defective. 
The mutant invertase is cleaved at a reduced rate at the 
adjacent ser-met bond. This alternate site has, according to 
von Heijne's rules (49), roughly equal probability of cleavage 
in the normal invertase signal peptide. Substitution of val at 
the normal site increases the probability of cleavage at the 
alternate site. Additional substitutions at the ser site may 
further reduce processing and secretion of invertase so that 
cells would be unable to grow on sucrose or raffinose as a 
carbon source. Such a situation could be used to obtain 
extragenic suppressor mutations among which signal pepti- 
dase mutants with altered substrate specificity may be found. 
It is not clear why the failure to remove a signal peptide 
has such a dramatic effect on invertase transport from the 
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ER. The reduced solubility and increased heterogeneity of 
accumulated s l invertase suggests that unprocessed enzyme 
either associates with a stable ER component or aggregates to 
a point where proper packaging for transport is hindered. In 
either case, the accumulation has no effect on transport of 
acid phosphatase, or cell surface growth, so it is unlikely that 
mutant invertase associates with and titrates some essential 
ER component. 
Other similar effects of signal peptide cleavage inhibition 
have been oted. Haguenauer-Tsapis and Hinnen (50) have 
deleted the cleavage site region of the yeast acid phosphatase 
gene (PH05) and find unprocessed, core-glycosylated nzyme 
accumulated within the cell which is only slowly secreted. 
Hortin and Boime (51, 52) report that incorporation of the 
threonine analogue, B-hydroxynorvaline, at the preprolactin 
signal cleavage site blocks proper processing. Precursors ac- 
cumulate in the ER in the unprocessed and in an alternatively 
processed form. This material is unstable and only slowly 
secreted in small amounts into the medium. Solubility and 
membrane association of the unprocessed preprolactin and 
acid phosphatase have not been investigated; however, failure 
to cleave the signal peptide of a mutant form of bacterial ~- 
lactamase results in association of the precursor with the 
external surface of the cytoplasmic membrane (53). 
There are many examples of proteins with uncleaved signal 
peptides, such as yeast a-factor (54), which nevertheless are 
transported rapidly from the ER. What then is the function 
of signal peptide cleavage? Wickner (55) has suggested that 
folding of membrane proteins and perhaps secretory proteins 
is influenced by the signal peptide. If so, signal peptide cleav- 
age early in the synthesis of a precursor could ensure correct 
folding. This appears not to be the case for sl mutant invertase 
and cleavage-deficient acid phosphatase (50); both are fully 
active enzymes. Perhaps certain signal peptides are cleaved to 
prevent association with a stable component of the ER. In 
this regard, some proteins are designed to remain in the ER, 
and may retain the signal peptide as a specific anchoring 
segment. 
s2 mutant invertase shows slow transport from the ER with 
no delay in signal peptide cleavage. With regard to enzyme 
activity, electrophoretic mobility, ease of release from the ER, 
and temperature stability, s2 mutant invertase resembles the 
normal enzyme accumulated in the ER in the pleiotropic 
mutant secl8. Although the mutation results in a hydrophobic 
substitution (thr ---, lie at position +64), no effect on subunit 
interaction or solubility in the presence or absence of deter- 
gent was detected. The effect on transport could be due to a 
subtle conformational change that influences mutant enzyme 
concentration i  a transitional zone of the ER, or to defective 
interaction with a receptor that mediates invertase movement. 
It is unlikely that the transport delay results from some 
nonspecific interaction between s2 mutant invertase and a 
membrane component because no block occurs in transit 
from the Golgi body to the cell surface. 
If the s2 mutation interferes with an ER transport signal, 
the interaction between mutant invertase and a receptor may 
be only partly defective, or the slower ate of transport may 
reflect a basal level of receptor-independent flow of soluble 
proteins to the Golgi body. These possibilities would be 
distinguished by the isolation of additional SUC2 mutations 
outside the signal peptide region that further slow the rate of 
transport. 
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